This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Curegenics Ltd., Pharmatwob Ltd.. Active years: 2008-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nes Ziona, IL (2008)
- Ness Ziona, IL (2016)
Company Filing History:
Years Active: 2008-2016
Certainly, here is the article about inventor Pninit Litman:
Title: Innovator Spotlight - Pninit Litman: Pioneering Advances in Pharmaceutical Therapies
Introduction:
Pninit Litman, a distinguished inventor hailing from Ness Ziona, Israel, has made remarkable contributions to the field of pharmaceuticals with his innovative patent creations. With a keen focus on developing effective treatment solutions for complex medical conditions, Litman has garnered acclaim for his groundbreaking work in the realm of Parkinson's disease and protein kinase inhibition.
Latest Patents:
1. Fixed Dose Combination Therapy of Parkinson's Disease: Litman's patented pharmaceutical composition offers a novel approach to treating Parkinson's disease by combining pramipexole and rasagiline in precise subtherapeutic doses. This innovative formulation holds promise for enhancing therapeutic outcomes while minimizing potential side effects.
2. Protein Kinase Inhibitors Comprising ATP Mimetics Conjugated to Peptides or Peptidomimetics: Litman's inventive compounds target protein kinases with exceptional affinity, utilizing ATP mimetics fused with peptide or peptidomimetic components. These chimeric inhibitors exhibit heightened efficacy and selectivity, showcasing immense potential for combating various diseases ranging from cancers to autoimmune disorders.
Career Highlights:
Throughout his career, Pninit Litman has demonstrated a steadfast commitment to pioneering advancements in pharmaceutical research. His tenure at esteemed companies such as Curegenics Ltd. and Pharmatwob Ltd. has been marked by a relentless pursuit of innovative solutions aimed at improving patient care and treatment outcomes.
Collaborations:
Litman's collaborative efforts with esteemed colleagues Nurit Livnah and Tamar Yechezkel have yielded fruitful results in the development of cutting-edge pharmaceutical therapies. Their synergistic work has contributed significantly to the advancement of precision medicine and targeted treatment modalities.
Conclusion:
In conclusion, Pninit Litman stands as a trailblazing figure in the realm of pharmaceutical innovations, with his patented creations poised to revolutionize the landscape of modern healthcare. Through his unwavering dedication to scientific excellence and collaborative spirit, Litman continues to shape the future of therapeutic interventions, offering hope and healing to countless individuals worldwide.
Is there anything else you would like to know about Pninit Litman or any other inventor?
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile